REFERENCES
- Chui DH. α-Thalassemia and population health in Southeast Asia. Ann Hum Biol 2005; 32(2)123–130
- Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, Li J, Chen HP, Xia YY, Wen YX, Mo QH, Li WD, Li YY, Zhuo LW, Wang ZQ, Chen YJ, Qin CH, Zhong M. The prevalence and spectrum of α and β thalassemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 2004; 57(5)517–522
- Liao C, Wei J, Li Q, Li J, Li L, Li D. Non-immune hydrops fetalis diagnosed during the second half pregnancy in Southern China. Fetal Diagn Ther 2007; 22(4)302–305
- Lam YH, Tang MH. Prenatal diagnosis of Hemoglobin Bart's disease by cordocentesis at 12–14 weeks' gestation. Prenat Diagn 1997; 17(6)501–504
- Lam YH, Ghosh A, Tang MH, Lee CP, Sin SY. Early ultrasound prediction of pregnancies affected by homozygous α-thalassemia-1. Prenat Diagn 1997; 17(4)327–332
- Lam YH, Tang MH, Lee CP, Tse HY. Prenatal ultrasonographic prediction of homozygous type 1 α-thalassemia at 12 to 13 weeks of gestation. Am J Obstet Gynecol 1999; 180(1)148–150
- Tongsong T, Wanapirak C, Sirichotiyakul S, Piyamongkol W, Chanprapaph P. Fetal sonographic cardiothoracic ratio at midpregnancy as a predictor of Hb Bart disease. J Ultrasound Med 1999; 18(12)807–811
- Tongsong T, Wanapirak C, Sirichotiyakul S, Chanprapaph P. Sonographic markers of Hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004; 23(1)49–55